Significant variations exist when contrasting cancer treatment approaches in the US and Europe. The American model, generally characterized by private insurance and a emphasis on innovation, often leads to rapid implementation of cutting-edge therapies, albeit at Difference between US and European cancer care a significantly higher cost. On the oth